Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

M.A. Dimopoulos, A. Palumbo, M. Attal, M. Beksac, F.E. Davies, M. Delforge, H. Einsele, R. Hajek, J.L. Harousseau, F.L. Da Costa, H. Ludwig, U.H. Mellqvist, G.J. Morgan, J.F. San-Miguel, S. Zweegman, P. Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)749-760
JournalLeukemia
Volume25
Issue number5
DOIs
Publication statusPublished - 2011

Cite this

Dimopoulos, M. A., Palumbo, A., Attal, M., Beksac, M., Davies, F. E., Delforge, M., ... Sonneveld, P. (2011). Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia, 25(5), 749-760. https://doi.org/10.1038/leu.2011.3